WORLDREMIT
4.2.2021 02:56:08 CET | Business Wire | Press release
WorldRemit, a leading digital cross-border payments business has announced the winners of its recent Grainsmart store franchise promotion to help customers give their beneficiaries the opportunity to start a business in the Philippines. Customers qualified for the promotion by sending money to the Philippines and nominating a beneficiary of their choice. The winners include frontline healthcare workers and teachers from a number of countries including the United Kingdom, Norway, Australia, Canada, New Zealand, Sweden and the United States. Beneficiaries will now be opening Grainsmart stores across the Philippines in places which include Cebu, Davao, San Carlos and Tagum City.
“We’re so pleased to give recipients this great opportunity to start a business that will help them to support their families and become more financially stable. The franchisees have the option to expand these businesses and potentially create job opportunities for members of the wider community. This underlines our commitment to helping Overseas Filipino Workers to support those dearest to them back home,” said Earl Melivo, Country Director for the Philippines at WorldRemit.
Benjamin Batac, CEO at Grainsmart added, “It’s an honour to partner with a company like WorldRemit that shares our values. With many of the franchise contracts already signed, this promotion will create sustainable jobs and also give much-needed support to Filipino farmers, many of whom are facing challenges due to the pandemic and recent natural disasters”.
Winner Emilie Ann Estavas who works as a healthcare assistant in a care home in Oxfordshire said, “I’m very happy and excited with the prize and so grateful to WorldRemit and Grainsmart. It is really a surprise. The Pangkabuhayan package will help my family back in the Philippines to start a business which is a huge blessing and a big help. It is a great opportunity and I’m planning to expand the business while we are here still working abroad. I am hoping and praying that God will bless the business and make it prosper so that in the near future it will help us to retire early, go home and continue running the business with my family. Fingers crossed!”.
Winner and frontline worker Melissa Zibas has chosen her cousin Adan who lives in San Carlos City, Pangasinan as her beneficiary. She said, “Adan is a former seafarer and is pretty adventurous like me so I know he’ll make a huge success of the Grainsmart business. We’re a very close family so I hope we can grow the business and include other members of our family. The covid-19 pandemic has really tested everyone's lives so it's great to start a business that will be needed by people as rice is our staple food”.
Rosa Mae who lives in Norway and is studying to become a youth worker, chose her sister Rhea as her beneficiary. Rhea who lives and works in Tagum City as a doctor’s secretary said, “I’m so grateful to my big sister for giving me this opportunity. I miss her so much now that she lives over 10,000 miles away in Oslo. Sending transfers through WorldRemit is her way of supporting and staying connected to us and now it has given me the chance to start my own business. We grew up in Davao de Oro and our parents still live there so I’m looking forward to running the Grainsmart franchise with them”.
Each Grainsmart franchise business package includes:
- 60 sacks (25 kg each) of rice
- A tablet that’s fully set up for a bills payment center account
- Business signage, marketing collateral, and other business paraphernalia
- An online training and mentorship program – to provide guidance for setting up the business for success
As well as the COVID-19 pandemic, Filipinos have also had to deal with the devastation caused by Super Typhoon Goni and Typhoon Vamco, which have displaced thousands and destroyed livelihoods.
Take advantage of competitive exchange rates for the Philippine peso by visiting www.worldremit.com or downloading the app.
Winners were announced on the WorldRemit Facebook page (https://www.facebook.com/WorldRemit/ ).
For more details visit www.worldremit.com/pangkabuhayan .
WorldRemit
WorldRemit is a leading digital cross-border payments business. We disrupted an industry previously dominated by offline legacy players by taking international money transfers online - making them safer, faster and lower-cost. We currently send from more than 50 countries to 130+ receive countries, operate in 6,500 money transfer corridors worldwide and employ over 1,100 people worldwide.
On the sending side WorldRemit is 100% digital (cashless), increasing convenience and enhancing security. For those receiving money, the company offers a wide range of options including bank deposit, cash collection, mobile airtime top-up and mobile money.
Backed by Accel, TCV and Leapfrog – WorldRemit’s headquarters are in London, United Kingdom with regional offices in the United States, Canada, Australia, New Zealand, Hong Kong, Singapore, Malaysia, the Philippines, South Africa, Somaliland, Uganda, Kenya, Rwanda, Tanzania, Zimbabwe and Belgium.
For more information visit www.worldremit.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203006021/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom